Cargando…
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic options. We undertook a focused compound screen (FCS) against 1097 compounds on three well‐characterized chordoma cell lines; 154 compounds were selected from the single concentration screen (1 µm), based on their...
Autores principales: | Scheipl, Susanne, Barnard, Michelle, Cottone, Lucia, Jorgensen, Mette, Drewry, David H, Zuercher, William J, Turlais, Fabrice, Ye, Hongtao, Leite, Ana P, Smith, James A, Leithner, Andreas, Möller, Peter, Brüderlein, Silke, Guppy, Naomi, Amary, Fernanda, Tirabosco, Roberto, Strauss, Sandra J, Pillay, Nischalan, Flanagan, Adrienne M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922416/ https://www.ncbi.nlm.nih.gov/pubmed/27102572 http://dx.doi.org/10.1002/path.4729 |
Ejemplares similares
-
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
por: Cottone, Lucia, et al.
Publicado: (2020) -
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice
por: Prendergast, Sophie C, et al.
Publicado: (2020) -
Synovial chondromatosis and soft tissue chondroma: extra-osseous cartilaginous tumours defined by FN1 gene rearrangement
por: Amary, Fernanda, et al.
Publicado: (2019) -
The driver landscape of sporadic chordoma
por: Tarpey, Patrick S., et al.
Publicado: (2017) -
Clinical outcome in patients with peripherally‐sited atypical lipomatous tumours and dedifferentiated liposarcoma
por: Kalimuthu, Sangeetha N, et al.
Publicado: (2015)